Tocris Caspase Inhibitors & Substrates
|
|
|
|
|
TocrisÀÇ Apoptosis pathwayÁß caspase¸¦ blockingÇÏ´Â inhibitor list¿Í substrates¸¦ ¼Ò°³ÇÕ´Ï´Ù. |
|
| TOCRIS |

Caspase Inhibitors
| Target |
Product |
Cat.No |
Biological Activity |
| Caspase 1 |
Z-VAD-FMK |
2163 |
Cell-permeable, irreversible pan-caspase inhibitor. Inhibits caspase processing and apoptosis induction in tumour cells in vitro (IC50 = 0.0015-5.8 ¥ìM). Active in vivo.
|
| Z-YVAD-FMK |
2164 |
Inhibitor of caspase-1 (ICE); inhibits apoptosis. |
| Caspase 2 |
Z-VDVAD-FMK |
2165 |
Irreversible caspase-2 inhibitor. Attenuates oxyhemoglobin-induced cleavage of PARP and apoptosis in endothelial cells.
|
| Caspase 3 |
Z-DQMD-FMK |
2168 |
Caspase-3 inhibitor. Inhibits MG 132-induced small cell lung cancer cell death in vitro.
|
| Ac-DEVD-AFC |
1573 |
Fluorogenic caspase substrate. Analog of the caspase-3-like substrate, DEVD-AFC. |
| Z-DEVD-FMK |
2166 |
Cell-permeable, irreversible inhibitor of caspase-3/CPP32; inhibits tumour cell apoptosis. Neuroprotective in rat hippocampus following seizures in vivo.
|
| Ivachtin |
2636 |
Potent, reversible inhibitor of caspase-3 (IC50 = 23 nM) that displays moderate selectivity over other caspases. Exhibits antiapoptotic activity in human Jurkat T cells treated with staurosporine; exhibits a higher level of protection than Z-VAD-FMK (Cat. No. 2163).
|
| Caspase 5 |
Z-WEHD-FMK |
2167 |
Caspase-5 inhibitor. Inhibits ECyd-induced rRNA fragmentation in mouse mammary tumour and human fibrosarcoma cells.
|
| Caspase 6 |
Z-VEID-FMK |
2169 |
Irreversible caspase-6 inhibitor. Inhibits nuclear protein cleavage in Fas antibody-treated HeLa cells.
|
| Caspase 8 |
Z-IETD-FMK |
2170 |
Inhibitor of caspase-8. Blocks TNF¥á-induced cytochrome c release and apoptosis in human leukemic U937 cells. Also inhibits nuclear protein cleavage in Jurkat, MCF-7 and HeLa cells in vitro.
|
| Caspase 9 |
Z-LEHD-FMK |
2171 |
Cell-permeable inhibitor of caspase-9. Inhibits MG 132-induced cancer cell death and protects isolated rat hearts against ischaemia-reperfusion injury. Neuroprotective following cerebral ischaemia in rats in vivo.
|
| Caspase 10 |
Z-AEVD-FMK |
N/A |
|
| Caspase 12 |
Z-ATAD-FMK |
N/A |
|
| Caspase 13 |
Z-LEED-FMK |
N/A |
|

Caspase Substrates
| Target |
Product |
Cat.No |
Biological Activity |
| Caspase 1 |
Ac-YVAD-AFC |
1572 |
Fluorogenic peptide substrate for caspase-1 (ICE). M.Wt:719.67 Formula:C33H36F3N5O10
|
| Caspase 3 |
Ac-DEVD-AFC |
1573 |
Fluorogenic caspase substrate. Analog of the caspase-3-like substrate, DEVD-AFC. M.Wt:729.62 Formula:C30H34F3N5O13
|
| Caspase 9 |
Ac-LEHD-AFC |
1575 |
Fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC. M.Wt:765.7 Formula:C33H38F3N7O11
|
| Granzyme B |
Ac-IEPD-AFC |
1576 |
Peptide sequence shown to be preferred recognition motif for the serine protease granzyme B. Fluorogenic substrate. M.Wt:725.67 Formula:C32H38F3N5O11
|